Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Return to the main site

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > FDAnews Drug Daily Bulletin > FDA OKs Horizon Pharma’s Time-Release Painkiller

FDAnews Drug Daily Bulletin

July 30, 2012 | Vol. 9 No. 148

FDA OKs Horizon Pharma’s Time-Release Painkiller

The Food and Drug Administration on Thursday gave the suburban biotech company Horizon Pharma the thumbs up on a new anti-inflammatory drug, the second the company will bring to market.
Chicago Tribune

Register Now
Print This Page
Email This Article
RSS
Archives

Related Articles

Full Issue FDA Denies Deston’s Petition to Market Ear Infection Drug DTC Marketing Study Implies Doctors Overprescribe Statins Pfizer Halts Phase III Trial of Lyphoma Drug After Interim Analysis

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.